BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thomas JP, Modos D, Rushbrook SM, Powell N, Korcsmaros T. The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease. Front Immunol 2022;13:829525. [PMID: 35185922 DOI: 10.3389/fimmu.2022.829525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Sharma S, Hegde P, Panda S, Orimoloye MO, Aldrich CC. Drugging the microbiome: targeting small microbiome molecules. Current Opinion in Microbiology 2023;71:102234. [DOI: 10.1016/j.mib.2022.102234] [Reference Citation Analysis]
2 Gautier T, Olivieiro N, Ferron S, Le Pogam P, David-le Gall S, Sauvager A, Leroyer P, Cannie I, Dion S, Sweidan A, Loréal O, Tomasi S, Bousarghin L. Bacteroides fragilis derived metabolites, identified by molecular networking, decrease Salmonella virulence in mice model. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1023315] [Reference Citation Analysis]
3 Zheng L. New insights into the interplay between intestinal flora and bile acids in inflammatory bowel disease. World J Clin Cases 2022; 10(30): 10823-10839 [DOI: 10.12998/wjcc.v10.i30.10823] [Reference Citation Analysis]
4 Gagnon W, Garneau V, Trottier J, Verreault M, Couillard C, Roy D, Marette A, Drouin-Chartier JP, Vohl MC, Barbier O. Impact of Blueberry Consumption on the Human Fecal Bileacidome: A Pilot Study of Bile Acid Modulation by Freeze-Dried Blueberry. Nutrients 2022;14:3857. [PMID: 36145234 DOI: 10.3390/nu14183857] [Reference Citation Analysis]
5 Zhang Y, Li Z, Gou H, Song X, Zhang L. The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis. Front Cell Infect Microbiol 2022;12:945368. [DOI: 10.3389/fcimb.2022.945368] [Reference Citation Analysis]
6 Hojo A, Kobayashi T, Matsubayashi M, Morikubo H, Miyatani Y, Fukuda T, Asonuma K, Sagami S, Nakano M, Matsuda T, Hibi T. Usefulness of colestimide for diarrhea in postoperative Crohn's disease. JGH Open 2022;6:547-553. [DOI: 10.1002/jgh3.12786] [Reference Citation Analysis]
7 Núñez-sánchez MA, Melgar S, O’donoghue K, Martínez-sánchez MA, Fernández-ruiz VE, Ferrer-gómez M, Ruiz-alcaraz AJ, Ramos-molina B. Crohn’s Disease, Host–Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches. IJMS 2022;23:8361. [DOI: 10.3390/ijms23158361] [Reference Citation Analysis]
8 Wang T, Wang X, Lee-sarwar K, Litonjua AA, Weiss ST, Sun Y, Maslov S, Liu Y. Predicting metabolomic profiles from microbial composition through neural ordinary differential equations.. [DOI: 10.1101/2022.06.23.497381] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Mamedova E, Árting LB, Rekling JC. Bile acids induce Ca2+ signaling and membrane permeabilizations in vagal nodose ganglion neurons. Biochem Biophys Rep 2022;31:101288. [PMID: 35669985 DOI: 10.1016/j.bbrep.2022.101288] [Reference Citation Analysis]
10 Pu D, Zhang Z, Feng B. Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases. Front Pharmacol 2022;13:906419. [DOI: 10.3389/fphar.2022.906419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]